Recent Updates
Recently added Catalysts
AMN

David Erdman Director, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES SECOND-QUARTER 2016 RESULTS Quarterly revenue a record high at $474 million; reports GAAP EPS of $0.53 and adjusted EPS of $0.61 SA

Key Takeaway: Contact: David Erdman Director, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES SECOND-QUARTER 2016 RESULTS Quarterly revenue a record high at $474 million; reports GAAP EPS of $0.53 and adjusted EPS of $0.61 SAN DIEGO (August 4, 2016) AMN Healthcare Services,

Full Press Release Details

Contact:
David Erdman
Director, Investor Relations
866.861.3229
AMN HEALTHCARE ANNOUNCES SECOND-QUARTER 2016 RESULTS
Quarterly revenue a record high at $474 million; reports GAAP EPS of $0.53 and adjusted EPS of $0.61
SAN DIEGO (August 4, 2016) AMN Healthcare Services, Inc. (NYSE: AHS), healthcare s leader and innovator in workforce solutions and staffing
services, today announced its second-quarter 2016 financial results, which exceeded the Company s guidance. Financial highlights are as follows:
Dollars in millions, except per share amounts.
Q2 2016 % Change Q2 2015 YTD June 30, 2016 % change YTD June 30, 2015
Revenue $ 473.7 35 % $ 941.7 39 %
Gross profit $ 154.8 41 % $ 306.7 45 %
Net income $ 26.3 66 % $ 52.2 86 %
Diluted EPS $ 0.53 66 % $ 1.06 83 %
Adjusted diluted EPS* $ 0.61 61 % $ 1.20 74 %
Adjusted EBITDA* $ 59.3 50 % $ 117.9 62 %
Second-Quarter 2016 Highlights
The AMN Healthcare team delivered another record quarter of revenue and earnings due to a strong market environment and tremendous
execution to address our client s critical and evolving workforce needs. In addition to the strong demand for staffing and placement services, we continue to increase the penetration of our workforce solutions, in particular MSP, VMS and
workforce optimization services, said Susan R. Salka, President and Chief Executive Officer of AMN Healthcare. The desire to build strategic partnerships and rising level of sophistication within healthcare creates great opportunity for
AMN to partner with our clients to deliver cost effective, quality patient care.
Second-Quarter 2016 Results
Consolidated revenue was $474 million, an increase of 35% from the same quarter last year, driven by 19% organic growth; revenue increased 1%
sequentially. Revenue for the Nurse and Allied Solutions segment was $293 million, an increase of 29% from the same quarter last year and down 2% sequentially. Locum Tenens Solutions revenue was $109 million, an increase of 12% from the same quarter
last year and 6% sequentially. Other Workforce Solutions segment revenue was $72 million, an increase of 174% from the same quarter last year and 7% sequentially. The Other Workforce Solutions segment revenue grew 32% organically from the prior year
with the remainder from recent acquisitions.
Gross margin was 32.7%, which is 130 basis points higher than the same quarter last year and
20 basis points higher sequentially. The year-over-year gross margin improvement continues to be primarily driven by growth in the higher-margin Other Workforce Solutions segment, along with a gross margin increase in the Locum Tenens Solution
SG&A expenses were $100 million, or 21.0% of revenue, compared to $75 million, or 21.3% of
revenue, in the same quarter last year and $98 million, or 20.9% of revenue, in the previous quarter. The 30 basis point decline in percentage of revenue year-over-year was driven by operating leverage.
Net income was $26 million, or $0.53 per diluted share. Excluding amortization of intangible assets and acquisition and integration costs, net
of tax, adjusted net income per diluted share was $0.61. Adjusted EBITDA was $59 million, a year-over-year increase of 50%. Adjusted EBITDA margin was 12.5%, representing a 130 basis point increase year-over-year and flat sequentially.
At June 30, 2016, cash and cash equivalents totaled $21 million. Cash flow from operations was $20 million and capital expenditures were
$6 million. The Company ended the quarter with total debt outstanding of $413 million, with a leverage ratio as calculated in accordance with our credit agreement of 1.9 to 1.
Third-Quarter 2016 Outlook
Metric Guidance*
Consolidated revenue $466 - $472 MM
Gross margin 32.5% - 33.0%
SG&A as percentage of revenue 21.5%
Adjusted EBITDA margin 11.5% - 12.0%
The Company s revenue guidance is based on the expectation of a continued strong demand environment, representing
year-over-year growth of approximately 22%.
Conference Call on August 4, 2016
AMN Healthcare Services, Inc. (NYSE: AHS), healthcare s leader and innovator in workforce solutions and staffing services, will host a
conference call to discuss its second-quarter 2016 financial results on Thursday, August 4, 2016 at 5:00 p.m. Eastern Time. A live webcast of
the call can be accessed through AMN Healthcare s website at http://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to
download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1059 in the U.S. or (612) 234-9960 internationally. Following the conclusion of the call, a replay of the webcast will be
available at the Company s website. Alternatively, a telephonic replay of the call will be available starting at 7:30 p.m. Eastern Time on August 4, 2016, and can be accessed until 11:59 p.m. Eastern Time on August 18, 2016 by calling
(800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 397211.
About AMN Healthcare
AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation.
The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps
providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process
outsourcing, predictive modeling, medical coding and consulting, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities and
many other healthcare settings.
The Company s common stock is listed on the New York Stock Exchange under the symbol
AHS. For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and
Really Simple Syndication ( RSS ) as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://amnhealthcare.investorroom.com/emailalerts.
release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company s condensed consolidated financial statements presented in accordance with GAAP. These
non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin and (3) adjusted diluted EPS. The Company provides such non-GAAP financial measures because
management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company s operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA
margin and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are not in accordance with, or an alternative
to, GAAP measures and may be different from non-GAAP measures, or may be calculated differently than other similarly title-captioned non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company s
performance. A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled Supplemental Financial
and Operating Data under the caption entitled Reconciliation of Non-GAAP Items, the table entitled Reconciliation of Guidance Adjusted EBITDA Margin to Guidance Operating Margin, and the footnotes thereto or on the
Company s website at http://amnhealthcare.investorroom.com/financialreports. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding the outlook for 2016, the favorable demand environment, third-quarter 2016 revenue, gross margin, SG&A expenses and
adjusted EBITDA margin. The Company based these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results
could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as believe, anticipate, expect, intend,
plan, will, may, estimates, variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or
circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press release are set forth in the Company s Annual Report on Form 10-K for
the year ended December 31, 2015 and its other
periodic reports as well as the Company s current and other reports filed from time to time with the Securities and Exchange Commission. Be advised that developments subsequent to this press
release are likely to cause these statements to become outdated.
Director, Investor Relations
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Comprehensive Income
(in thousands, except per share amounts)
Three Months Ended Six Months Ended
June 30, March 31, June 30,
2016 2015 2016 2016 2015
Revenue $ 473,729 $ 350,144 $ 468,002 $ 941,731 $ 677,654
Cost of revenue 318,976 240,026 316,104 635,080 466,104
Gross profit 154,753 110,118 151,898 306,651 211,550
Gross margin 32.7 % 31.4 % 32.5 % 32.6 % 31.2 %
Operating expenses:
Selling, general and administrative (SG&A) 99,541 74,727 97,823 197,364 146,279
SG&A as a % of revenue 21.0 % 21.3 % 20.9 % 21.0 % 21.6 %
Depreciation and amortization 7,334 5,232 6,765 14,099 10,327
Total operating expenses 106,875 79,959 104,588 211,463 156,606
Income from operations 47,878 30,159 47,310 95,188 54,944
Operating margin (1) 10.2 % 8.6 % 10.2 % 10.1 % 8.1 %
Interest expense, net, and other 2,800 1,977 3,249 6,049 3,784
Income before income taxes 45,078 28,182 44,061 89,139 51,160
Income tax expense 18,756 12,312 18,192 36,948 23,081
Net income $ 26,322 $ 15,870 $ 25,869 $ 52,191 $ 28,079
Net income as a % of revenue 5.6 % 4.5 % 5.6 % 5.6 % 4.1 %
Other comprehensive income (loss):
Foreign currency translation 86 (80 ) 39 125 (12 )
Unrealized gain (loss) on cash flow hedge, net of income taxes (111 ) 36 (463 ) (574 ) 36
Other comprehensive income (loss) (25 ) (44 ) (424 ) (449 ) 24
Comprehensive income $ 26,297 $ 15,826 $ 25,445 $ 51,742 $ 28,103
Net income per common share:
Basic $ 0.55 $ 0.33 $ 0.54 $ 1.09 $ 0.59
Diluted $ 0.53 $ 0.32 $ 0.53 $ 1.06 $ 0.58
Weighted average common shares outstanding:
Basic 48,034 47,573 47,894 47,964 47,361
Diluted 49,348 48,863 49,103 49,225 48,615
AMN Healthcare Services, Inc.
Supplemental Financial and Operating Data
(dollars in thousands, except per share data)
Three Months Ended Six Months Ended
June 30, March 31, June 30,
2016 2015 (2) 2016 2016 2015 (2)
Revenue
Nurse and allied solutions $ 292,663 $ 226,494 $ 297,724 $ 590,387 $ 443,486
Locum tenens solutions 109,129 97,388 102,738 211,867 184,080
Other workforce solutions 71,937 26,262 67,540 139,477 50,088
$ 473,729 $ 350,144 $ 468,002 $ 941,731 $ 677,654
Reconciliation of Non-GAAP Items:
Segment operating income (3)
Nurse and allied solutions $ 39,503 $ 31,159 $ 41,618 $ 81,121 $ 58,521
Locum tenens solutions 16,317 11,711 13,291 29,608 20,821
Other workforce solutions 17,858 7,513 17,586 35,444 15,323
73,678 50,383 72,495 146,173 94,665
Unallocated corporate overhead 14,420 11,006 13,805 28,225 21,966
Adjusted EBITDA (4) 59,258 39,377 58,690 117,948 72,699
Adjusted EBITDA margin (5) 12.5 % 11.2 % 12.5 % 12.5 % 10.7 %
Depreciation and amortization 7,334 5,232 6,765 14,099 10,327
Share-based compensation 2,710 2,153 3,381 6,091 4,530
Acquisition and integration costs 1,336 1,833 1,234 2,570 2,898
Income from operations 47,878 30,159 47,310 95,188 54,944
Interest expense, net, and other 2,800 1,977 3,249 6,049 3,784
Income before income taxes 45,078 28,182 44,061 89,139 51,160
Income tax expense 18,756 12,312 18,192 36,948 23,081
Net income $ 26,322 $ 15,870 $ 25,869 $ 52,191 $ 28,079
GAAP diluted net income per share (EPS) $ 0.53 $ 0.32 $ 0.53 $ 1.06 $ 0.58
Adjustments:
Amortization of intangible assets 0.09 0.06 0.09 0.18 0.12
Acquisition and integration costs 0.03 0.04 0.03 0.05 0.06
Tax effect of adjustments (0.04 ) (0.04 ) (0.05 ) (0.09 ) (0.07 )
Adjusted diluted EPS (6) $ 0.61 $ 0.38 $ 0.60 $ 1.20 $ 0.69
Three Months Ended Six Months Ended
June 30, March 31, June 30,
2016 2015 2016 2016 2015
Gross Margin
Nurse and allied solutions 26.7 % 27.2 % 26.6 % 26.7 % 26.9 %
Locum tenens solutions 31.3 % 29.2 % 31.0 % 31.1 % 29.3 %
Other workforce solutions 58.9 % 76.0 % 60.3 % 59.6 % 76.3 %
Operating Data:
Nurse and allied solutions
Average healthcare professionals on assignment (7) 8,337 7,227 8,474 8,406 7,225
Revenue per healthcare professional per day (8) $ 386 $ 344 $ 386 $ 386 $ 339
Locum tenens solutions
Days filled (9) 61,068 59,844 58,166 119,234 114,104
Revenue per day filled (10) $ 1,787 $ 1,627 $ 1,766 $ 1,777 $ 1,613
As of June 30, As of March 31,
2016 2015 2016
Leverage ratio (11) 1.9 1.9 1.9
AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(dollars in thousands)
June 30, March 31, December 31,
2016 2016 2015
Assets
Current assets:
Cash and cash equivalents $ 21,062 $ 23,106 $ 9,576
Accounts receivable, net 330,853 302,342 277,996
Accounts receivable, subcontractor 46,326 49,858 50,807
Prepaid and other current assets 44,332 37,656 37,249
Total current assets 442,573 412,962 375,628
Restricted cash and cash equivalents 28,490 27,176 27,352
Fixed assets, net 56,575 53,731 50,134
Other assets 54,759 52,993 47,569
Goodwill 342,827 307,161 204,779
Intangible assets, net 255,214 240,478 174,970
Total assets $ 1,180,438 $ 1,094,501 $ 880,432
Liabilities and stockholders equity
Current liabilities:
Accounts payable and accrued expenses $ 131,965 $ 109,121 $ 118,822
Accrued compensation and benefits 102,516 98,049 83,701
Current portion of revolving credit facility 40,000 40,000 30,000
Current portion of notes payable 11,250 11,250 7,500
Deferred revenue 6,145 8,436 5,620
Other current liabilities 9,728 23,998 5,374
Total current liabilities 301,604 290,854 251,017
Revolving credit facility 166,500 127,500 52,500
Notes payable, less unamortized fees 194,019 196,746 128,490
Deferred income taxes, net 30,921 22,514 22,431
Other long-term liabilities 84,495 83,076 78,134
Total liabilities 777,539 720,690 532,572
Commitments and contingencies
Stockholders equity 402,899 373,811 347,860
Total liabilities and stockholders equity $ 1,180,438 $ 1,094,501 $ 880,432
AMN Healthcare Services, Inc.
Summary Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
Three Months Ended Six Months Ended
June 30, March 31, June 30,
2016 2015 2016 2016 2015
Net cash provided by operating activities $ 20,053 $ 25,000 $ 35,227 $ 55,280 $ 33,687
Net cash used in investing activities (58,451 ) (9,516 ) (174,703 ) (233,154 ) (94,866 )
Net cash provided by (used in) financing activities 36,268 (12,563 ) 152,967 189,235 62,592
Effect of exchange rates on cash 86 (80 ) 39 125 (12 )
Net increase (decrease) in cash and cash equivalents (2,044 ) 2,841 13,530 11,486 1,401
Cash and cash equivalents at beginning of period 23,106 11,633 9,576 9,576 13,073
Cash and cash equivalents at end of period $ 21,062 $ 14,474 $ 23,106 $ 21,062 $ 14,474
AMN Healthcare Services, Inc.
Additional Supplemental Non-GAAP Disclosures
Reconciliation of Guidance Adjusted EBITDA Margin to
Guidance Operating Margin
Three Months Ending
September 30, 2016
Low High
Adjusted EBITDA margin 11.5 % 12.0 %
Deduct:
Share-based compensation 0.6%
Acquisition and integration costs 0.2%
EBITDA margin 10.7 % 11.2 %
Depreciation and amortization 1.7%
Operating margin 9.0 % 9.5 %
Last updated: Aug 4, 2016